Summary
SALES of the swine flu vaccine are expected to deliver a pounds 1.5bn boost to Britain's biggest drug companies in the final three months of 2009.
GlaxoSmithKline and AstraZeneca have both developed vaccines and are in line for a "bumper" fourth quarter, according to analysts.See the full content of this document
Extract
Shot in the Arm for Drug Companies
Countries have begun vaccination programmes as the northern hemisphere prepares for a second wave of swine flu during the winter.
The two companies will report third-quarter results this week and are e...See the full content of this document

